SEI Investments
NWBO

SEI Investments’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

SEI Investments’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-32,148
Closed -$201K – 2922
2015
Q3 		$201K Buy
+32,148
New +$301K ﹤0.01% 1605

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SEI Investments's NWBO Position: Q4 2015 in Review

SEI Investments sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2015, closing a stake of 32,148 shares — an estimated $201K sold.

SEI Investments first reported a position in NWBO in Q3 2015 and held it in 1 quarter. The position peaked at $201K in Q3 2015. 80 funds tracked by Wall St. Rank hold NWBO as of Q4 2015.

  • SEI Investments reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2015 after selling out during the quarter.
  • SEI Investments sold 32,148 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2015, an estimated $201K.
  • SEI Investments first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2015 and held it in 1 quarter.
  • SEI Investments's Northwest Biotherapeutics, Inc. Common stock position peaked at $201K in Q3 2015.
  • 80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2015.

Based on SEI Investments's 13F filing for Q4 2015, filed 3 Feb 2016.